Despite progress, Drug-Resistant TB (DR-TB) remains a major public health emergency in India, accounting for a quarter of the global burden. The crisis is worsened by diagnostic delays, toxic treatments, and social inequities. Tackling it requires political resolve for universal testing, newer regimens like BPaLM, and integrated survivor-centred care.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›India's Global DR-TB Share: Almost a quarter (25%)
- ›Annual New DR-TB Cases: 1.3-1.5 lakh (WHO, 2025)
- ›Target this Data: India's share of global DR-TB burden (~25%) and annual new cases (1.3-1.5 lakh).
- ›Target this Nodal Body: World Health Organization (WHO) for the Global TB Report and National Tuberculosis Elimination Programme (NTEP) for Nikshay Portal.
- ›Target this Initiative: Nikshay Portal for TB case notification and the BPaLM regimen for DR-TB treatment.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.